Centessa Pharmaceuticals
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. The net income raised on -$151,085,000 and profit margin reached -2205%. Total operating expenses were $178,136,000.
Profit Margin
| 2019 | 0 | -5.28M | |
|---|---|---|---|
| 2020 | 0 | -11.04M | |
| 2021 | 0 | -381.85M | |
| 2022 | 0 | -216.20M | |
| 2023 | 6.85M | -151.08M | -2204.65% |
CNTA Income Statement (2019 β 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|
Revenue | |||||
Revenue | 6.85M | 0 | 0 | 0 | 0 |
Cost of revenue | 0 | 130.91K | 33.99K | 0 | 0 |
Gross profit | 6.85M | -130.91K | -33.99K | 0 | 0 |
Operating exp. | |||||
Research and development | 124.40M | 155.08M | 96.31M | 9.30M | 4.26M |
Selling and marketing | 0 | 0 | 42.92M | 0 | 0 |
Total operating expenses | 178.13M | 210.28M | 139.28M | 10.44M | 5.05M |
Operating income | -171.28M | -212.26M | -139.31M | -10.44M | -5.05M |
Other income (expenses), net | -4.85M | -4.69M | -242.42M | -223K | -8K |
Income before tax | -176.14M | -216.95M | -381.74M | -10.66M | -5.06M |
Income tax expense | -25.05M | -747K | 113.98K | 378K | 223K |
Net income | -151.08M | -216.20M | -381.85M | -11.04M | -5.28M |
Earnings per share | |||||
Basic EPS | -1.57 | -2.31 | -4.24 | -0.07 | -0.07 |
Diluted EPS | -1.57 | -2.31 | -4.24 | -0.07 | -0.07 |
| Data source | Data source | Data source |